Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

sagi habasov

559 POSTS

Exclusive articles:

BUUU Group’s $6M Nasdaq Debut: Hong Kong MICE Operator Targets Scale, Brand and U.S. Market Entry

BUUU Group Limited, a Hong Kong-based provider of event management and stage production services across the MICE value chain, priced its U.S. IPO at...

Tailwind 2.0 Acquisition’s $150 Million SPAC: A Focused Bet on the “Intelligence Layer” of Energy and Compute

Tailwind 2.0 Acquisition Corp. has filed to raise $150 million in a Nasdaq-listed SPAC, positioning itself squarely at the intersection of power infrastructure and...

Highview Merger Corp. Launches $200 Million IPO: A Strategic Move in the SPAC Market

Highview Merger Corp., a newly formed special purpose acquisition company (SPAC) targeting middle-market businesses in North America and Western Europe, has successfully priced its...

U.S. IPO Market in 2025: A Resurgence Amidst Uncertainty

After a prolonged lull precipitated by geopolitical volatility, interest rate pressures, and elevated uncertainty, the U.S. IPO market has staged a notable comeback in...

Elite Express Holding Inc. (ETS) Files for $18.4 Million NASDAQ IPO

Elite Express Holding Inc. (NASDAQ: ETS) has officially filed to go public on the NASDAQ Capital Market, targeting an offering of 4,000,000 shares at...

Breaking

SKN | Geothermal Developer Fervo Energy Files for Estimated $250 Million IPO

Fervo Energy, a next-generation geothermal energy developer, has filed...

SKN | Mobia Medical Files for $100M IPO as Neurostimulation Therapy Targets $30B Stroke Market

FDA-Approved Device Positions Company in High-Value Neurorehabilitation Segment Mobia Medical...

SKN | Amatuhi Holdings Raises IPO Range as Investor Demand Lifts Expected Proceeds by 60%

Revised Pricing Signals Stronger Market Interest Ahead of Nasdaq...

SKN | Alamar Biosciences Prices Upsized IPO at $17, the High End of the Range

Alamar Biosciences has priced its upsized initial public offering...
spot_imgspot_img